• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » SS Innovations beats The Street on Q2 sales as it eyes U.S., EU expansion

SS Innovations beats The Street on Q2 sales as it eyes U.S., EU expansion

August 14, 2026 By Mary Salmonsen

A photo of SS Innovations CEO Dr. Sudhir Srivastava operating with SSi's MantrAsana tele-surgeon console in Georgetown, Guayana.
SS Innovations CEO Dr. Sudhir Srivastava operating with SSi’s MantrAsana tele-surgeon console in Georgetown, Guyana. [Image courtesy of the company]
SS Innovations (Nasdaq: SSII) second quarter results met Wall Street consensus expectations on earnings while beating revenue forecasts.

In the earnings report out yesterday, the India-based robotic surgery company reported a net loss of $2.7 million, or 1¢ per share, on revenue of $13.9 million for the three months ended June 30, 2026. Losses were tenfold what they were in Q2 2025, while revenue was up 39.4%.

Revenue beat The Street’s consensus of $11.7 million estimate, with analysts on average expecting the penny EPS loss.

As of midday today, SSII shares were up more than 2% to $3.88 apiece this week on the earnings news. The S&P 500 was up 0.38%.

“SS Innovations delivered record quarterly revenue…reflecting strong adoption of our advanced SSi Mantra surgical robotic system by leading hospitals and surgeons in India and abroad,” said Dr. Sudhir Srivastava, chairman of the board and chief executive officer of SS Innovations. “We continue to expand awareness of the SSi Mantra’s cutting-edge surgical robotic technology, differentiated features, user friendliness, training capabilities, and cost efficiency.”

The company reported 30 new installations of its SSi Mantra surgical robotic systems in the second quarter, up 30.4% from 23 installations in the second quarter of 2025. The company’s install base now totals 224 systems across 12 countries, which have performed over 12,200 surgeries total.

SS Innovations did not provide a specific financial forecast, but Dr. Srivastava noted that the company intends to expand its market presence in India and its global footprint. The company is targeting approval for its systems in the United States and European Union.

“We expect the U.S. Food and Drug Administration to complete its review of our 510(k) premarket notification for the SSi Mantra by the end of the first quarter of 2027,” Dr. Srivastava said. “We also continue along the pathway towards a European Union CE marking certification for the SSi Mantra, which we believe we can obtain by the end of 2026.  Our SSI Mantra has been engineered for precision, built to perform, and created to democratize access to advanced surgical robotic care—all underpinning our confidence in the future.”

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Robotic-Assisted, Surgical Robotics, Wall Street Beat Tagged With: SS Innovations

More recent news

  • Massachusetts Life Sciences Center offers grants to lower medtech commercial risk
  • The 10 largest medical device companies
  • CSL to drop Terumo for Haemonetics in US plasma collection supply deal
  • How 5 medtech CEOs design for access
  • Butterfly Network to chase ultrasound brain-computer interfaces with newcomer Bridge Neurotech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy